Abeona Therapeutics Inc • ABEO

Capital at risk.

About Abeona Therapeutics Inc
Ticker
info
ABEO
Trading on
info
NASDAQ
ISIN
info
US00289Y1073
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Vishwas Seshadri M.B.A., Ph.D.
Headquarters
info
6555 Carnegie Avenue, Cleveland, OH, United States, 44103
Employees
info
84
Website
info
abeonatherapeutics.com
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in Cleveland, Ohio.
Metrics
BasicAdvanced
Market cap
info
$227M
P/E ratio
info
-
EPS
info
-$2.05
Dividend Yield
info
0.00%
Beta
info
1.78
Forward P/E ratio
info
0
EBIDTA
info
$-58.8M
Ex dividend date
info
-
Price & volume
Market cap
info
$227M
Average daily volume
info
0.4M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
0
Trailing P/E
info
0
Price to sales
info
61.63
Price to book
info
4.94
Earnings
EPS
info
-$2.05
EPS estimate (current quarter)
info
-$0.42
EPS estimate (next quarter)
info
-$0.42
EBITDA
info
$-58.8M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
1.78
52-week High
info
$8.45
52-week Low
info
$3.05
50-day moving average
info
$5.48
200-day moving average
info
$5.51
Short ratio
info
9.7
Short %
info
6.11%
Management effectiveness
ROE (TTM)
info
209.50%
ROA (TTM)
info
40.68%
Profit margin
info
0.00%
Gross profit margin
info
$-31.4M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
100.00%
Share stats
Outstanding Shares
info
43.6M
Float
info
29.1M
Insiders %
info
5.45%
Institutions %
info
76.50%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 4 analysts.

Average price target

info
$15.92
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.77
-$0.47
63.83%
Q4 • 23Beat
-$1.16
-$0.51
127.45%
Q1 • 24Beat
$0.19
-$0.36
152.78%
Q2 • 24Beat
-$0.31
-$0.40
21.43%
Q3 • 24Beat
-
-
-
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$7.4M
∞%
Q2 • 24
$0M
$-30.3M
∞%
Q3 • 24
NaN%
508.71%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$134M
$60.8M
45.34%
Q2 • 24
$121M
$74.8M
62.04%
Q3 • 24
10.01%
23.13%
36.83%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-12.7M
$-44.1M
$73.7M
$-13.4M
Q2 • 24
$-12.2M
$-6.2M
$-0.3M
$-12.6M
Q3 • 24
3.55%
86.03%
100.41%
5.65%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Abeona Therapeutics Inc share?
Collapse

Abeona Therapeutics Inc shares are currently traded for undefined per share.

How many shares does Abeona Therapeutics Inc have?
Collapse

Abeona Therapeutics Inc currently has 43.6M shares.

Does Abeona Therapeutics Inc pay dividends?
Collapse

No, Abeona Therapeutics Inc doesn't pay dividends.

What is Abeona Therapeutics Inc 52 week high?
Collapse

Abeona Therapeutics Inc 52 week high is $8.45.

What is Abeona Therapeutics Inc 52 week low?
Collapse

Abeona Therapeutics Inc 52 week low is $3.05.

What is the 200-day moving average of Abeona Therapeutics Inc?
Collapse

Abeona Therapeutics Inc 200-day moving average is $5.51.

Who is Abeona Therapeutics Inc CEO?
Collapse

The CEO of Abeona Therapeutics Inc is Dr. Vishwas Seshadri M.B.A., Ph.D..

How many employees Abeona Therapeutics Inc has?
Collapse

Abeona Therapeutics Inc has 84 employees.

What is the market cap of Abeona Therapeutics Inc?
Collapse

The market cap of Abeona Therapeutics Inc is $227M.

What is the P/E of Abeona Therapeutics Inc?
Collapse

The current P/E of Abeona Therapeutics Inc is null.

What is the EPS of Abeona Therapeutics Inc?
Collapse

The EPS of Abeona Therapeutics Inc is -$2.05.

What is the PEG Ratio of Abeona Therapeutics Inc?
Collapse

The PEG Ratio of Abeona Therapeutics Inc is 0.

What do analysts say about Abeona Therapeutics Inc?
Collapse

According to the analysts Abeona Therapeutics Inc is considered a buy.